Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 6/20 | 0.36 |
| ▸ | CTSD | P07339 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17483020 | 0.94 | KDM4E (0.39) | BACE1CTSDKDM4EALDH1A1GAA | |
| SCHEMBL17482874 | 0.91 | PDK2 (0.38) | PDK2BACE1CTSDKDM4EALDH1A1 | |
| SCHEMBL17482903 | 0.91 | KDM4E (0.39) | BACE1CTSDKDM4EALDH1A1GAA | |
| SCHEMBL17482885 | 0.90 | KDM4E (0.36) | BACE1CTSDKDM4EALDH1A1GAA | |
| SCHEMBL17483018 | 0.85 | PDK2 (0.36) | PDK2BACE1CTSDKCNH2PRKDC | |
| SCHEMBL17482878 | 0.81 | PDK2 (0.37) | PDK2BACE1CTSDKCNH2PRKDC | |
| SCHEMBL17482887 | 0.81 | PDK2 (0.35) | PDK2BACE1CTSDKCNH2PRKDC | |
| SCHEMBL17482788 | 0.80 | PDK2 (0.45) | PDK2BACE1CTSDKDM4EALDH1A1 | |
| SCHEMBL17482779 | 0.80 | PDK2 (0.45) | PDK2BACE1CTSDKDM4EALDH1A1 | |
| SCHEMBL17482899 | 0.80 | ALOX5 (0.37) | BACE1KDM4EALDH1A1AHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160035986-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-02-04 | — | — | US | disclosed |
| US-20160035986-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160035986-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | PDK2 2404/4885BACE1 533/4885CTSD 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.